FDA

5 statements across 4 episodes · 2 bullish · 0 bearish · 5 people on the record · first statement Jun 10, 2025 by Jackie DeMarco · across every show →

Everything said about FDA, oldest first

Jun 10, 2025 positive
Assertion Supported
Jackie DeMarco: FDA cleared IMAGExRAY device for infants over four weeks
“And during the FDA process, they said, okay, you can use it on babies aged four weeks and older.”
Jackie DeMarco Jun 10, 2025 ▶ 8:29 Revolutionizing Dysphagia Diagnosis: IMAGExRAY’s Technology is Transforming Healthcare
Jun 10, 2025 neutral
Assertion Not checkable as stated
Steve DeMarco: IMAGExRAY Took Nine Months to Gain FDA Approval
“Now the process took Nine months, I think, from, you know, the initial creation to the actual approval and significant investment in, in experts time.”
Steve DeMarco Jun 10, 2025 ▶ 17:29 Revolutionizing Dysphagia Diagnosis: IMAGExRAY’s Technology is Transforming Healthcare
Jul 25, 2025 positive
Disclosure
Kluz: Niterra Ventures invested in synthetic skin startup Imbed Biosciences
“And then kind of connected to that, we invested in another company in the advanced wound care space called Embed Biosciences. That's a synthetic skin that gets applied to wounds. It's really interesting. The FDA approved for two indications.”
Thomas Kluz Jul 25, 2025 ▶ 5:07 Strategic Corporate Venture Capital in Automotive, Healthcare, and Climate Tech with Niterra Ventures
Sep 5, 2025
Disclosure
Frist Cressey writes $5M to $15M checks, skipping FDA-regulated deals
“So very practically we write five to fifteen million dollar checks and seed and series a stage businesses healthcare technology, healthcare services The things we don't do is anything that requires FDA approval. So think med device, life sciences, biotech, tho…”
Matt Schappell Sep 5, 2025 ▶ 3:36 Matt Schappell on Healthcare Innovation: Investing in Tech-Driven Value-Based Care
Jun 9, 2026
Assertion Supported
Shotsy hired a former FDA informatics chief scientist as its CSO
“We were very fortunate to bring on a chief science officer last year who was a former chief scientist at the FDA for informatics and spent, Has spent a lot of his career focused on health data privacy and you know, issues around regulation with apps like this.”
Aja Beckett Jun 9, 2026 ▶ 7:42 Innovating the GLP-1 Health App Market with Aja Beckett of Shotsy | The Innovators & Investors Podcast
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.